Non-interventional study -observe treatment efficacy in maintaining symptoms control in schizophrenia with Seroquel XR
Study identifier:NIS-NRO-SER-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Non-interventional study to observe treatment efficacy in maintaining symptoms control in patients with schizophrenia, treated with Seroquel XR
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
578
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Aug 2008
Primary Completion Date: 01 Sept 2009
Study Completion Date: 01 Sept 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Schizophrenia patients stabilized on Seroquel XR | - |
Contacts
Investigators
Principal Investigator
Beatrice Costea
AstraZeneca
